NURSl 5432/l NURS5432l Finall Examl
(NEWl 2026l Update)l –l Familyl Il (FNPl 1)l
Reviewl |l Questionsl &l Answersl |l Gradel
A|l 100%l Correctl (Verifiedl Solutions)-l
UTA
QUESTION
Whatl isl thel ACHESl mnemonic?
Answer:
Symptomsl tol reportl tol al provider:l Abdl pain,l Chestl pain,l Headaches,l Eyel problems,l
Severel legl pain.
QUESTION
Whatl arel thel contraindicationsl forl estrogenl usel inl menopausall women?
Answer:
Historyl ofl bloodl clots,l CAD,l breastl orl ovarianl cancer,l liverl disease,l andl estrogen-
dependentl tumors.
QUESTION
Whatl isl hormonel replacementl therapyl (HRT)?
Answer:
Treatmentl tol minimizel moderatel tol severel vasomotorl symptoms,l usingl estrogenl andl
progesterone.
QUESTION
Whatl isl thel recommendedl treatmentl forl womenl withoutl al hysterectomy?
,Answer:
Estrogenl plusl progesteronel tol preventl endometriall hyperplasia.
QUESTION
Whatl arel non-hormonall medicationsl usedl forl menopause?
Answer:
Paroxetine,l venlafaxine,l fluoxetine,l gabapentin,l andl clonidinel forl treatingl hotl flashes.
QUESTION
Isl hormonel therapyl safel forl long-terml use?
Answer:
No,l long-terml usel increasesl risksl ofl CVD,l cancer,l andl VTE;l itl shouldl bel usedl atl thel
lowestl effectivel dosel forl thel shortestl time.
QUESTION
Whatl isl thel treatmentl goall forl HRT?
Answer:
Tol minimizel moderatel tol severel vasomotorl symptoms.
QUESTION
Whatl isl thel significancel ofl elevatedl FSHl levelsl inl menopause?
Answer:
Anl elevatedl FSHl levell greaterl thanl 30l indicatesl ovarianl failure.
QUESTION
Whatl isl thel rolel ofl DEXAl scansl inl menopause?
,Answer:
Tol diagnosel osteoporosis,l recommendedl startingl atl agel 65l orl 60l forl smokers.
QUESTION
Whatl lifestylel changesl canl reducel CVDl riskl inl menopausall women?
Answer:
Increasingl exercise,l avoidingl tobacco,l managingl hypertension,l hyperlipidemia,l andl
diabetes.
QUESTION
Whatl isl thel recommendedl calciuml andl vitaminl Dl intakel forl post-menopausall women?
Answer:
1200l mg/dayl ofl calciuml andl 800-1200l IU/dayl ofl vitaminl D.
QUESTION
Whatl isl thel typicall bonel lossl ratel forl womenl duringl menopause?
Answer:
3-5%l perl yearl forl thel firstl 5-7l yearsl post-menopause.
QUESTION
Whatl typesl ofl cancersl requirel anl oncologist'sl consultationl beforel initiatingl estrogenl
therapy?
Answer:
Breastl cancerl (BRCA1l andl BRCA2),l ovarianl cancer,l andl uterinel cancer.
QUESTION
Whatl isl al riskl associatedl withl higherl dosesl ofl estrogen?
, Answer:
Increasedl hypercoagulability,l whichl canl leadl tol venousl thromboembolisml (VTE)l orl
cerebrovascularl accidentsl (CVA).
QUESTION
Whatl shouldl estrogenl notl bel prescribedl for?
Answer:
Cardioprotectivel benefits.
QUESTION
Whatl conditionl canl higherl dosesl ofl estrogenl inducel relatedl tol bloodl pressure?
Answer:
Hypertension.
QUESTION
Whatl isl thel effectl ofl topicall estrogenl therapyl onl vulvar/vaginall atrophy?
Answer:
Itl reversesl vaginall atrophy,l enhancesl bloodl flow,l andl reducesl urinaryl tractl infectionsl
(UTIs).
QUESTION
Howl shouldl topicall estrogenl therapyl bel administeredl initially?
Answer:
Startl withl dailyl applicationl forl 1-2l weeks,l thenl decreasel tol al fewl timesl al week.
QUESTION
Whatl isl Ospemifenel usedl for?
(NEWl 2026l Update)l –l Familyl Il (FNPl 1)l
Reviewl |l Questionsl &l Answersl |l Gradel
A|l 100%l Correctl (Verifiedl Solutions)-l
UTA
QUESTION
Whatl isl thel ACHESl mnemonic?
Answer:
Symptomsl tol reportl tol al provider:l Abdl pain,l Chestl pain,l Headaches,l Eyel problems,l
Severel legl pain.
QUESTION
Whatl arel thel contraindicationsl forl estrogenl usel inl menopausall women?
Answer:
Historyl ofl bloodl clots,l CAD,l breastl orl ovarianl cancer,l liverl disease,l andl estrogen-
dependentl tumors.
QUESTION
Whatl isl hormonel replacementl therapyl (HRT)?
Answer:
Treatmentl tol minimizel moderatel tol severel vasomotorl symptoms,l usingl estrogenl andl
progesterone.
QUESTION
Whatl isl thel recommendedl treatmentl forl womenl withoutl al hysterectomy?
,Answer:
Estrogenl plusl progesteronel tol preventl endometriall hyperplasia.
QUESTION
Whatl arel non-hormonall medicationsl usedl forl menopause?
Answer:
Paroxetine,l venlafaxine,l fluoxetine,l gabapentin,l andl clonidinel forl treatingl hotl flashes.
QUESTION
Isl hormonel therapyl safel forl long-terml use?
Answer:
No,l long-terml usel increasesl risksl ofl CVD,l cancer,l andl VTE;l itl shouldl bel usedl atl thel
lowestl effectivel dosel forl thel shortestl time.
QUESTION
Whatl isl thel treatmentl goall forl HRT?
Answer:
Tol minimizel moderatel tol severel vasomotorl symptoms.
QUESTION
Whatl isl thel significancel ofl elevatedl FSHl levelsl inl menopause?
Answer:
Anl elevatedl FSHl levell greaterl thanl 30l indicatesl ovarianl failure.
QUESTION
Whatl isl thel rolel ofl DEXAl scansl inl menopause?
,Answer:
Tol diagnosel osteoporosis,l recommendedl startingl atl agel 65l orl 60l forl smokers.
QUESTION
Whatl lifestylel changesl canl reducel CVDl riskl inl menopausall women?
Answer:
Increasingl exercise,l avoidingl tobacco,l managingl hypertension,l hyperlipidemia,l andl
diabetes.
QUESTION
Whatl isl thel recommendedl calciuml andl vitaminl Dl intakel forl post-menopausall women?
Answer:
1200l mg/dayl ofl calciuml andl 800-1200l IU/dayl ofl vitaminl D.
QUESTION
Whatl isl thel typicall bonel lossl ratel forl womenl duringl menopause?
Answer:
3-5%l perl yearl forl thel firstl 5-7l yearsl post-menopause.
QUESTION
Whatl typesl ofl cancersl requirel anl oncologist'sl consultationl beforel initiatingl estrogenl
therapy?
Answer:
Breastl cancerl (BRCA1l andl BRCA2),l ovarianl cancer,l andl uterinel cancer.
QUESTION
Whatl isl al riskl associatedl withl higherl dosesl ofl estrogen?
, Answer:
Increasedl hypercoagulability,l whichl canl leadl tol venousl thromboembolisml (VTE)l orl
cerebrovascularl accidentsl (CVA).
QUESTION
Whatl shouldl estrogenl notl bel prescribedl for?
Answer:
Cardioprotectivel benefits.
QUESTION
Whatl conditionl canl higherl dosesl ofl estrogenl inducel relatedl tol bloodl pressure?
Answer:
Hypertension.
QUESTION
Whatl isl thel effectl ofl topicall estrogenl therapyl onl vulvar/vaginall atrophy?
Answer:
Itl reversesl vaginall atrophy,l enhancesl bloodl flow,l andl reducesl urinaryl tractl infectionsl
(UTIs).
QUESTION
Howl shouldl topicall estrogenl therapyl bel administeredl initially?
Answer:
Startl withl dailyl applicationl forl 1-2l weeks,l thenl decreasel tol al fewl timesl al week.
QUESTION
Whatl isl Ospemifenel usedl for?
